FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 321:76-79 July 13, 1989 Number 2 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Experimental studies in animals have demonstrated that the topical application of epidermal growth factor accelerates the rate of epidermal regeneration of partial-thickness wounds and second-degree burns. We conducted a prospective, randomized, double-blind clinical trial using skin-graft-donor sites to determine whether epidermal growth factor would accelerate the rate of epidermal regeneration in humans. Paired donor sites were created in 12 patients who required skin grafting for either burns or reconstructive surgery. One donor site from each patient was treated topically with silver sulfadiazine cream, and one was treated with silver sulfadiazine cream containing epidermal growth factor (10 micrograms per milliliter). The donor sites were photographed daily, and healing was measured with the use of planimetric analysis. The donor sites treated with silver sulfadiazine containing epidermal growth factor had an accelerated rate of epidermal regeneration in all 12 patients as compared with that in the paired donor sites treated with silver sulfadiazine alone. Treatment with epidermal growth factor significantly decreased the average length of time to 25 percent and 50 percent healing by approximately one day and that to 75 percent and 100 percent healing by approximately 1.5 days (P less than 0.02). Histologic evaluation of punch-biopsy specimens taken from the centers of donor sites three days after the onset of healing supported these results. We conclude that epidermal growth factor accelerates the rate of healing of partial-thickness skin wounds. Further studies are required to determine the clinical importance of this finding.

Source Information

Department of Surgery, Emory University, Atlanta.

This article has been cited by other articles:

• (2008). Review Paper: Considerations for Determining if a Natural Product Is an Effective Wound-Healing Agent. INT J LOW EXTREM WOUNDS 7: 75-81  
• Parvadia, J. K., Keswani, S. G., Vaikunth, S., Maldonado, A. R., Marwan, A., Stehr, W., Erwin, C., Uzvolgyi, E., Warner, B. W., Yamano, S., Taichman, N., Crombleholme, T. M. (2007). Role of VEGF in small bowel adaptation after resection: the adaptive response is angiogenesis dependent. Am. J. Physiol. Gastrointest. Liver Physiol. 293: G591-G598 [Abstract] [Full Text]  
• Huang, T.-H., Morrison, S. L. (2006). A Trimeric Anti-HER2/neu ScFv and Tumor Necrosis Factor-{alpha} Fusion Protein Induces HER2/neu Signaling and Facilitates Repair of Injured Epithelia. J. Pharmacol. Exp. Ther. 316: 983-991 [Abstract] [Full Text]  
• Kansra, S., Stoll, S. W., Johnson, J. L., Elder, J. T. (2004). Autocrine Extracellular Signal-regulated Kinase (ERK) Activation in Normal Human Keratinocytes: Metalloproteinase-mediated Release of Amphiregulin Triggers Signaling from ErbB1 to ERK. Mol. Biol. Cell 15: 4299-4309 [Abstract] [Full Text]  
• Haase, I., Evans, R., Pofahl, R., Watt, F. M. (2003). Regulation of keratinocyte shape, migration and wound epithelialization by IGF-1- and EGF-dependent signalling pathways. J. Cell Sci. 116: 3227-3238 [Abstract] [Full Text]  
• Sinha, A., Nightingale, J. M.D., West, K. P., Berlanga-Acosta, J., Playford, R. J. (2003). Epidermal Growth Factor Enemas with Oral Mesalamine for Mild-to-Moderate Left-Sided Ulcerative Colitis or Proctitis. NEJM 349: 350-357 [Abstract] [Full Text]  
• Denkbas, E. B., Ozturk, E., Ozdemi, N., Kececi, K., Ergun, M. A. (2003). EGF Loaded Chitosan Sponges as Wound Dressing Material. Journal of Bioactive and Compatible Polymers 18: 177-190 [Abstract]  
• Shiraha, H., Glading, A., Chou, J., Jia, Z., Wells, A. (2002). Activation of m-Calpain (Calpain II) by Epidermal Growth Factor Is Limited by Protein Kinase A Phosphorylation of m-Calpain. Mol. Cell. Biol. 22: 2716-2727 [Abstract] [Full Text]  
• Hardie, W. D., Prows, D. R., Piljan-Gentle, A., Dunlavy, M. R., Wesselkamper, S. C., Leikauf, G. D., Korfhagen, T. R. (2002). Dose-Related Protection from Nickel-Induced Lung Injury in Transgenic Mice Expressing Human Transforming Growth Factor-alpha. Am. J. Respir. Cell Mol. Bio. 26: 430-437 [Abstract] [Full Text]  
• Leikauf, G. D., McDowell, S. A., Wesselkamper, S. C., Hardie, W. D., Leikauf, J. E., Korfhagen, T. R., Prows, D. R. (2002). Acute Lung Injury : Functional Genomics and Genetic Susceptibility. Chest 121: 70S-75S [Abstract] [Full Text]  
• van den Aardweg, G J M J, Morris, G M, Bywaters, A, Bakker, E J, Mooi, W J (2001). Changes in epidermal radiosensitivity with time associated with increased colony numbers. Br. J. Radiol. 74: 434-444 [Abstract] [Full Text]  
• Hom, D. B. (2000). A New Era of Discovery in Facial Plastic Surgery. Arch Facial Plast Surg 2: 166-172 [Abstract] [Full Text]  
• Robson, M. C., Hill, D. P., Woodske, M. E., Steed, D. L. (2000). Wound Healing Trajectories as Predictors of Effectiveness of Therapeutic Agents. Arch Surg 135: 773-777 [Abstract] [Full Text]  
• Sabini, P., Sclafani, A. P., Romo III, T., McCormick, S. A., Cocker, R. (2000). Modulation of Tissue Ingrowth Into Porous High-Density Polyethylene Implants With Basic Fibroblast Growth Factor and Autologous Blood Clot. Arch Facial Plast Surg 2: 27-33 [Abstract] [Full Text]  
• Lee, Y.-J., Streuli, C. H. (1999). Extracellular Matrix Selectively Modulates the Response of Mammary Epithelial Cells to Different Soluble Signaling Ligands. J. Biol. Chem. 274: 22401-22408 [Abstract] [Full Text]  
• Pilcher, B. K., Dumin, J., Schwartz, M. J., Mast, B. A., Schultz, G. S., Parks, W. C., Welgus, H. G. (1999). Keratinocyte Collagenase-1 Expression Requires an Epidermal Growth Factor Receptor Autocrine Mechanism. J. Biol. Chem. 274: 10372-10381 [Abstract] [Full Text]  
• Paladini, R. D., Coulombe, P. A. (1998). Directed Expression of Keratin 16 to the Progenitor Basal Cells of Transgenic Mouse Skin Delays Skin Maturation. J. Cell Biol. 142: 1035-1051 [Abstract] [Full Text]  
• Jaakkola, P., Kontusaari, S., Kauppi, T., Määttä, A., Jalkanen, M. (1998). Wound reepithelialization activates a growth factor-responsive enhancer in migrating keratinocytes. FASEB J. 12: 959-969 [Abstract] [Full Text]  
• McCawley, L. J., O'Brien, P., Hudson, L. G. (1997). Overexpression of the Epidermal Growth Factor Receptor Contributes to Enhanced Ligand-Mediated Motility in Keratinocyte Cell Lines. Endocrinology 138: 121-127 [Abstract] [Full Text]  
• Matthay, M., Thiery, J., Lafont, F, Stampfer, F, Boyer, B (1993). Transient effect of epidermal growth factor on the motility of an immortalized mammary epithelial cell line. J. Cell Sci. 106: 869-878 [Abstract]  
• Finley, R. S. (1991). Overview of Biotechnology in Health Care. Journal of Pharmacy Practice 4: 80-86  
• Wokalek, H., Ruh, H. (1991). Time Course of Wound Healing. J Biomater Appl 5: 337-362 [Abstract]  
• (1989). EPIDERMAL GROWTH FACTOR ENHANCES WOUND HEALING. JWatch General 1989: 1-1 [Full Text]  
• Shiraha, H., Gupta, K., Drabik, K., Wells, A. (2000). Aging Fibroblasts Present Reduced Epidermal Growth Factor (EGF) Responsiveness Due to Preferential Loss of EGF Receptors. J. Biol. Chem. 275: 19343-19351 [Abstract] [Full Text]